- Home
- IPHA vs ECBK Comparison
IPHA vs ECBK Comparison
Compare IPHA & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- ECBK
- Stock Information
- Founded
- IPHA 1999
- ECBK 1919
- Country
- IPHA France
- ECBK United States
- Employees
- IPHA N/A
- ECBK N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- ECBK Banks
- Sector
- IPHA Health Care
- ECBK Finance
- Exchange
- IPHA Nasdaq
- ECBK Nasdaq
- Market Cap
- IPHA 160.1M
- ECBK 137.7M
- IPO Year
- IPHA 2019
- ECBK N/A
- Fundamental
- Price
- IPHA $1.97
- ECBK $15.54
- Analyst Decision
- IPHA Strong Buy
- ECBK
- Analyst Count
- IPHA 1
- ECBK 0
- Target Price
- IPHA $11.50
- ECBK N/A
- AVG Volume (30 Days)
- IPHA 28.5K
- ECBK 23.0K
- Earning Date
- IPHA 03-27-2025
- ECBK 04-28-2025
- Dividend Yield
- IPHA N/A
- ECBK N/A
- EPS Growth
- IPHA N/A
- ECBK N/A
- EPS
- IPHA N/A
- ECBK 0.48
- Revenue
- IPHA $20,831,349.00
- ECBK $26,040,000.00
- Revenue This Year
- IPHA $220.44
- ECBK N/A
- Revenue Next Year
- IPHA $81.85
- ECBK N/A
- P/E Ratio
- IPHA N/A
- ECBK $32.38
- Revenue Growth
- IPHA N/A
- ECBK 4.00
- 52 Week Low
- IPHA $1.29
- ECBK $11.39
- 52 Week High
- IPHA $3.51
- ECBK $15.75
- Technical
- Relative Strength Index (RSI)
- IPHA 53.30
- ECBK 62.38
- Support Level
- IPHA $1.81
- ECBK $14.73
- Resistance Level
- IPHA $2.00
- ECBK $15.19
- Average True Range (ATR)
- IPHA 0.14
- ECBK 0.32
- MACD
- IPHA 0.02
- ECBK 0.01
- Stochastic Oscillator
- IPHA 53.76
- ECBK 94.27
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.